Senators propose relaxing FDA conflict rules
WASHINGTON (Reuters) - A bill that would loosen conflict of interest rules for advisers to the Food and Drug Administration has been proposed by three U.S. senators seeking to speed up review times for medical devices.

Insmed Incorporated Provides Regulatory Update on ARIKACE in Non-Tuberculous Mycobacteria Indication
Insmed Incorporated , a biopharmaceutical company, today announced that the Company has been notified by the U.S. Food and Drug Administration that it is continuing the clinical hold previously placed on Insmed's phase 3 clinical trial for ARIKACE in patients with non-tuberculous mycobacterial lung disease.